{"transactions":[{"id":3558369,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-10","kind":"sale","acquired":false,"shares":374,"price":29.3952,"value":10993.8048,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.71, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":47471,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3558368,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-10","kind":"sale","acquired":false,"shares":13157,"price":29.3952,"value":386752.6464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.71, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1672105,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3558367,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":377,"price":28.5305,"value":10755.9985,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.02 to $29.685, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":47845,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3558366,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":13292,"price":28.5305,"value":379227.406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.02 to $29.685, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1685262,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3558365,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-08","kind":"sale","acquired":false,"shares":629,"price":29.4919,"value":18550.4051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.13 to $30.08, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":48222,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3558364,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T19:21:59.000Z","date":"2019-04-08","kind":"sale","acquired":false,"shares":22171,"price":29.4919,"value":653864.9149,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.13 to $30.08, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1698554,"source":{"system":"sec-edgar","filing":"0000899243-19-010492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319010492/doc4.xml","form_type":"4"}},{"id":3568442,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":253,"price":28.7638,"value":7277.2414,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.53 to $29.14, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":48851,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3568441,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":8888,"price":28.7638,"value":255652.6544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.53 to $29.14, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1720725,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3568440,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":1458,"price":27.6582,"value":40325.6556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $28.78, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":49104,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3568439,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":51373,"price":27.6582,"value":1420884.7086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $28.78, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1729613,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3568438,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-03-29","kind":"sale","acquired":false,"shares":969,"price":28.396,"value":27515.724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $29.13, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":50562,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3568437,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T18:57:58.000Z","date":"2019-03-29","kind":"sale","acquired":false,"shares":34133,"price":28.396,"value":969240.668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $29.13, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1780986,"source":{"system":"sec-edgar","filing":"0000899243-19-009640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009640/doc4.xml","form_type":"4"}},{"id":3575116,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-28","kind":"sale","acquired":false,"shares":1012,"price":27.801,"value":28134.612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $29.10, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":51531,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3575115,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-28","kind":"sale","acquired":false,"shares":35653,"price":27.801,"value":991189.053,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $29.10, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1815119,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3575114,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-27","kind":"sale","acquired":false,"shares":1599,"price":29.0592,"value":46465.6608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 to $30.425, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":52543,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3575113,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-27","kind":"sale","acquired":false,"shares":56318,"price":29.0592,"value":1636556.0256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 to $30.425, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1850772,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3575112,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-26","kind":"sale","acquired":false,"shares":831,"price":29.6975,"value":24678.6225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.68 to $30.01, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":54142,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3575111,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-28T17:29:52.000Z","date":"2019-03-26","kind":"sale","acquired":false,"shares":29262,"price":29.6975,"value":869008.245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.68 to $30.01, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":1907090,"source":{"system":"sec-edgar","filing":"0000899243-19-009178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319009178/doc4.xml","form_type":"4"}},{"id":3584539,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-20T16:13:54.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":7246,"price":26.7,"value":193468.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are held directly by Strategic Partners."}],"balance_after":54973,"source":{"system":"sec-edgar","filing":"0000899243-19-008526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319008526/doc4.xml","form_type":"4"}},{"id":3584538,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-20T16:13:54.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":255224,"price":26.7,"value":6814480.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":1936352,"source":{"system":"sec-edgar","filing":"0000899243-19-008526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319008526/doc4.xml","form_type":"4"}},{"id":3608243,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T09:05:30.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":893,"price":23.0365,"value":20571.5945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.52 to $23.34, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":62219,"source":{"system":"sec-edgar","filing":"0000899243-19-006369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319006369/doc4.xml","form_type":"4"}},{"id":3608242,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T09:05:30.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":31439,"price":23.0365,"value":724244.5235,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.52 to $23.34, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2191576,"source":{"system":"sec-edgar","filing":"0000899243-19-006369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319006369/doc4.xml","form_type":"4"}},{"id":3608241,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T09:05:30.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":1197,"price":22.907,"value":27419.679,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.02 to $23.02, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":63112,"source":{"system":"sec-edgar","filing":"0000899243-19-006369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319006369/doc4.xml","form_type":"4"}},{"id":3608240,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T09:05:30.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":42181,"price":22.907,"value":966240.167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.02 to $23.02, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2223015,"source":{"system":"sec-edgar","filing":"0000899243-19-006369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319006369/doc4.xml","form_type":"4"}},{"id":3641669,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":4764,"price":20.6,"value":98138.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":64309,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3641668,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-21","kind":"sale","acquired":false,"shares":167779,"price":20.6,"value":3456247.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2265196,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3641667,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":641,"price":20.0159,"value":12830.1919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.115, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":69073,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3641666,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":22594,"price":20.0159,"value":452239.2446,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.115, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2432975,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3641665,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":508,"price":20.7328,"value":10532.2624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $21.61, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":69714,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3641664,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T14:35:52.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":17912,"price":20.7328,"value":371365.9136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $21.61, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2455569,"source":{"system":"sec-edgar","filing":"0000899243-19-004359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319004359/doc4.xml","form_type":"4"}},{"id":3701845,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-07T17:12:06.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":72,"price":20.412,"value":1469.664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.82, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":70222,"source":{"system":"sec-edgar","filing":"0000899243-19-000686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000686/doc4.xml","form_type":"4"}},{"id":3701844,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-07T17:12:06.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":2527,"price":20.412,"value":51581.124,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.82, inclusive. The Reporting Persons undertake to provide to Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2473481,"source":{"system":"sec-edgar","filing":"0000899243-19-000686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000686/doc4.xml","form_type":"4"}},{"id":3701843,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-07T17:12:06.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":47,"price":20.013,"value":940.611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.04, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":70294,"source":{"system":"sec-edgar","filing":"0000899243-19-000686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000686/doc4.xml","form_type":"4"}},{"id":3701842,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-07T17:12:06.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":1653,"price":20.013,"value":33081.489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.04, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the  Funds except to the extent of any pecuniary interest therein."}],"balance_after":2476008,"source":{"system":"sec-edgar","filing":"0000899243-19-000686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000686/doc4.xml","form_type":"4"}},{"id":3713071,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":6,"price":20,"value":120.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":70341,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3713070,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":194,"price":20,"value":3880.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":2477661,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3713069,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2018-12-31","kind":"sale","acquired":false,"shares":702,"price":20.004,"value":14042.808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.32, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":70347,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3713068,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2018-12-31","kind":"sale","acquired":false,"shares":24716,"price":20.004,"value":494418.864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.32, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":2477855,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3713067,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2018-12-28","kind":"sale","acquired":false,"shares":103,"price":20.027,"value":2062.781,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.195, inclusive.  The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":71049,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3713066,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T19:10:56.000Z","date":"2018-12-28","kind":"sale","acquired":false,"shares":3631,"price":20.027,"value":72718.037,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.195, inclusive.  The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":2502571,"source":{"system":"sec-edgar","filing":"0000899243-19-000172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924319000172/doc4.xml","form_type":"4"}},{"id":3721209,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T16:19:53.000Z","date":"2018-12-19","kind":"sale","acquired":false,"shares":59,"price":20.018,"value":1181.062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.16, inclusive.  The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These shares are held directly by Strategic Partners."}],"balance_after":71152,"source":{"system":"sec-edgar","filing":"0000899243-18-031591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924318031591/doc4.xml","form_type":"4"}},{"id":3721208,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T16:19:53.000Z","date":"2018-12-19","kind":"sale","acquired":false,"shares":2077,"price":20.018,"value":41577.386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.16, inclusive.  The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein."}],"balance_after":2506202,"source":{"system":"sec-edgar","filing":"0000899243-18-031591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000089924318031591/doc4.xml","form_type":"4"}},{"id":4471295,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163335,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","position":2,"cik":"0001233315","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163334,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","position":3,"cik":"0001233226","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":4,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":5,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163336,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","position":6,"cik":"0001172861","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-02-02T16:10:55.000Z","date":"2017-01-31","kind":"sale","acquired":false,"shares":8501,"price":17,"value":144517.0,"ownership":{"direct":false,"nature":"By Fund IV Strategic"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SV Life Sciences Fund IV (GP), L.P. (\"Fund IV GP\") is the general partner of each of SV Life Sciences Fund IV, L.P. (\"Fund IV\") and SV Life Sciences Fund IV Strategic Partners, L.P.  (\"Fund IV Strategic\" and together with Fund IV, the \"Fund IV Entities\").  SVLSF IV, LLC (the \"SVLS General Partner\") is the general partner of Fund IV GP and, through an investment committee comprised of David Milne (also a member of the Issuer's board of directors), James Garvey, Kate Bingham, Eugene D. Hill, III and Michael Ross controls voting and investment decisions over the Issuer's shares held by the Fund IV Entities by a majority vote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each member of the investment committee of SVLS General Partner disclaims beneficial ownership over the Shares held by the Fund IV Entities except to the extent of any pecuniary interest therein.  Each of SVLS General Partner and Fund IV GP disclaim beneficial ownership over the Shares held by the Fund IV Entities except to the extent of their respective pecuniary interest therein."}],"balance_after":50849,"source":{"system":"sec-edgar","filing":"0001235802-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1172861/000123580217000022/primary_doc.xml","form_type":"4"}},{"id":4471294,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163335,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","position":2,"cik":"0001233315","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163334,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","position":3,"cik":"0001233226","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":4,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":5,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163336,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","position":6,"cik":"0001172861","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-02-02T16:10:55.000Z","date":"2017-01-31","kind":"sale","acquired":false,"shares":299424,"price":17,"value":5090208.0,"ownership":{"direct":false,"nature":"By Fund IV"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SV Life Sciences Fund IV (GP), L.P. (\"Fund IV GP\") is the general partner of each of SV Life Sciences Fund IV, L.P. (\"Fund IV\") and SV Life Sciences Fund IV Strategic Partners, L.P.  (\"Fund IV Strategic\" and together with Fund IV, the \"Fund IV Entities\").  SVLSF IV, LLC (the \"SVLS General Partner\") is the general partner of Fund IV GP and, through an investment committee comprised of David Milne (also a member of the Issuer's board of directors), James Garvey, Kate Bingham, Eugene D. Hill, III and Michael Ross controls voting and investment decisions over the Issuer's shares held by the Fund IV Entities by a majority vote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each member of the investment committee of SVLS General Partner disclaims beneficial ownership over the Shares held by the Fund IV Entities except to the extent of any pecuniary interest therein.  Each of SVLS General Partner and Fund IV GP disclaim beneficial ownership over the Shares held by the Fund IV Entities except to the extent of their respective pecuniary interest therein."}],"balance_after":1791070,"source":{"system":"sec-edgar","filing":"0001235802-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1172861/000123580217000022/primary_doc.xml","form_type":"4"}},{"id":4471293,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163335,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","position":2,"cik":"0001233315","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163334,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","position":3,"cik":"0001233226","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":4,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":5,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163336,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","position":6,"cik":"0001172861","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-02-02T16:10:55.000Z","date":"2017-01-31","kind":"sale","acquired":false,"shares":2106,"price":17,"value":35802.0,"ownership":{"direct":false,"nature":"By ILSF Strategic"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"International Life Sciences Fund III (GP), L.P. (\"Fund III GP\") is the general partner of each of: (i) International Life Sciences Fund III (LP1), L.P. (\"ILSF LP1\"), (ii) International Life Sciences Fund III Co-Investment, L.P. (\"ILSF Co-Invest\") and (iii) International Life Sciences Fund III Strategic Partners, L.P. (\"ILSF Strategic\" and collectively, the \"Fund III Entities\").  ILSF III, LLC (the \"ILSF General Partner\") is the general partner of Fund III GP and, through an investment committee comprised of James Garvey, Kate Bingham, Eugene D. Hill, III and Michael Ross controls voting and investment decisions over the Issuer's shares held by the Fund III Entities by majority vote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each member of the investment committee of ILSF General Partner disclaims beneficial ownership over the Shares held by the Fund III Entities except to the extent of any pecuniary interest therein. Each of ILSF General Partner and Fund III GP disclaim beneficial ownership over the Shares held by the Fund III Entities except to the extent of their respective pecuniary interest therein."}],"balance_after":10424,"source":{"system":"sec-edgar","filing":"0001235802-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1172861/000123580217000022/primary_doc.xml","form_type":"4"}},{"id":4471292,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163335,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","position":2,"cik":"0001233315","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163334,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","position":3,"cik":"0001233226","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":4,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":5,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163336,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","position":6,"cik":"0001172861","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-02-02T16:10:55.000Z","date":"2017-01-31","kind":"sale","acquired":false,"shares":2615,"price":17,"value":44455.0,"ownership":{"direct":false,"nature":"By ILSF Co-Invest"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"International Life Sciences Fund III (GP), L.P. (\"Fund III GP\") is the general partner of each of: (i) International Life Sciences Fund III (LP1), L.P. (\"ILSF LP1\"), (ii) International Life Sciences Fund III Co-Investment, L.P. (\"ILSF Co-Invest\") and (iii) International Life Sciences Fund III Strategic Partners, L.P. (\"ILSF Strategic\" and collectively, the \"Fund III Entities\").  ILSF III, LLC (the \"ILSF General Partner\") is the general partner of Fund III GP and, through an investment committee comprised of James Garvey, Kate Bingham, Eugene D. Hill, III and Michael Ross controls voting and investment decisions over the Issuer's shares held by the Fund III Entities by majority vote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each member of the investment committee of ILSF General Partner disclaims beneficial ownership over the Shares held by the Fund III Entities except to the extent of any pecuniary interest therein. Each of ILSF General Partner and Fund III GP disclaim beneficial ownership over the Shares held by the Fund III Entities except to the extent of their respective pecuniary interest therein."}],"balance_after":12947,"source":{"system":"sec-edgar","filing":"0001235802-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1172861/000123580217000022/primary_doc.xml","form_type":"4"}},{"id":4471291,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163335,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","position":2,"cik":"0001233315","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163334,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","position":3,"cik":"0001233226","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":4,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":5,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163336,"kind":"organization","name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","position":6,"cik":"0001172861","reported_name":"INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-02-02T16:10:55.000Z","date":"2017-01-31","kind":"sale","acquired":false,"shares":220431,"price":17,"value":3747327.0,"ownership":{"direct":false,"nature":"By ILSF LP1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"International Life Sciences Fund III (GP), L.P. (\"Fund III GP\") is the general partner of each of: (i) International Life Sciences Fund III (LP1), L.P. (\"ILSF LP1\"), (ii) International Life Sciences Fund III Co-Investment, L.P. (\"ILSF Co-Invest\") and (iii) International Life Sciences Fund III Strategic Partners, L.P. (\"ILSF Strategic\" and collectively, the \"Fund III Entities\").  ILSF III, LLC (the \"ILSF General Partner\") is the general partner of Fund III GP and, through an investment committee comprised of James Garvey, Kate Bingham, Eugene D. Hill, III and Michael Ross controls voting and investment decisions over the Issuer's shares held by the Fund III Entities by majority vote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each member of the investment committee of ILSF General Partner disclaims beneficial ownership over the Shares held by the Fund III Entities except to the extent of any pecuniary interest therein. Each of ILSF General Partner and Fund III GP disclaim beneficial ownership over the Shares held by the Fund III Entities except to the extent of their respective pecuniary interest therein."}],"balance_after":1091166,"source":{"system":"sec-edgar","filing":"0001235802-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172861/000123580217000022/primary_doc.xml","form_type":"4"}},{"id":4542082,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-25T21:05:02.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":71211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for 191,091 shares of KalVista Pharmaceuticals, Ltd. Series A Preferred shares and 53,523 shares of Series B Preferred shares in connection with the closing of the Transaction. On the effective date of the Transaction, the closing price of the Company's common stock was $9.38 per share. All numbers give effect to the Reverse Stock Split. Prior to the Reverse Stock Split, the closing price of the Company's common stock was $0.67 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of SVLS IV LP and Strategic Partners, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLS IV GP disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLSF IV, LLC disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest ther"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These shares are held directly by Strategic Partners."}],"balance_after":71211,"source":{"system":"sec-edgar","filing":"0001140361-16-087888","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000114036116087888/doc1.xml","form_type":"4"}},{"id":4542081,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":106574,"kind":"organization","name":"SVLSF IV, LLC","position":1,"cik":"0001422339","reported_name":"SVLSF IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106575,"kind":"organization","name":"SV Life Sciences Fund IV (GP), L.P.","position":2,"cik":"0001422340","reported_name":"SV Life Sciences Fund IV (GP), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158426,"kind":"organization","name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","position":3,"cik":"0001392309","reported_name":"SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158427,"kind":"organization","name":"SV LIFE SCIENCES FUND IV, L.P.","position":4,"cik":"0001367381","reported_name":"SV LIFE SCIENCES FUND IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-25T21:05:02.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":2508279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 6,730,810 shares of KalVista Pharmaceuticals, Ltd. Series A Preferred shares and 1,885,228 shares of Series B Preferred shares in connection with the closing of the share purchase transaction (the \"Transaction\") whereby KalVista Pharmaceuticals, Ltd. became a wholly-owned subsidiary of Carbylan Therapeutics, Inc., which changed its name to KalVista Pharmaceuticals, Inc. (the \"Company\"). On the effective date of the Transaction, the closing price of the Company's common stock was $9.38 per share. All numbers give effect to the 14:1 reverse stock split effected by the Company on November 21, 2016 (the \"Reverse Stock Split\"). Prior to the reverse stock split, the closing price of the Company's common stock was $0.67 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held directly by SVLS IV LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"SVLS IV LP and Strategic Partners (each a \"Fund\", or collectively the \"Funds\") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of SVLS IV LP and Strategic Partners, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLS IV GP disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by SVLS IV LP and Strategic Partners. SVLSF IV, LLC disclaims beneficial ownership of shares held by SVLS IV LP and Strategic Partners except to the extent of any pecuniary interest ther"}],"balance_after":2508279,"source":{"system":"sec-edgar","filing":"0001140361-16-087888","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422340/000114036116087888/doc1.xml","form_type":"4"}}]}